Sanofi-Aventis Recherche & Developpement

Immune-Mediated Inflammatory Diseases

Clinical research includes ulcerative colitis, Crohn’s disease, rheumatoid arthritis, systemic lupus erythematosus, and systemic juvenile idiopathic arthritis, with additional interest in coeliac disease and chronic graft versus host disease.

  • Ulcerative colitis
  • Crohn’s disease
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Chronic graft versus host disease

Research also extends to immune thrombocytopenia, autoimmune haemolytic anaemia, and other immune system diseases.

Dermatology and Allergic Disease

Studies cover atopic dermatitis, psoriasis, hidradenitis suppurativa, pruritus, and chronic rhinosinusitis with nasal polyps, alongside asthma and other respiratory tract diseases.

  • Atopic dermatitis
  • Psoriasis
  • Hidradenitis suppurativa
  • Asthma
  • Chronic rhinosinusitis with nasal polyps

Additional activity includes chronic obstructive pulmonary disease and bronchiectasis within broader respiratory disease research.

Haematology, Oncology, and Plasma Cell Disorders

Research spans multiple myeloma, plasma cell myeloma, relapsed/refractory multiple myeloma, acute myeloid leukemia, acute lymphocytic leukaemia, and myelodysplastic syndrome.

  • Multiple myeloma
  • Acute myeloid leukemia
  • Acute lymphocytic leukaemia
  • Myelodysplastic syndrome
  • Non-small cell lung cancer

Other areas include solid tumours, plasma cell myeloma recurrent, and light-chain amyloidosis.

Neurology and Neuromuscular Disorders

Clinical studies address multiple sclerosis, relapsing multiple sclerosis, progressive multiple sclerosis, amyotrophic lateral sclerosis, and chronic inflammatory demyelinating polyneuropathy.

  • Multiple sclerosis
  • Amyotrophic lateral sclerosis
  • Chronic inflammatory demyelinating polyneuropathy
  • Polyneuropathy
  • Neurological disorders

Research also includes inflammatory demyelinating polyradiculoneuropathy and broader nervous system diseases.

Metabolic, Genetic, and Rare Diseases

Work in this area includes type 1 diabetes mellitus, Fabry disease, Gaucher’s disease type III, glycogen storage disease type II, and achondroplasia.

  • Type 1 diabetes mellitus
  • Fabry disease
  • Gaucher’s disease type III
  • Achondroplasia
  • Congenital, hereditary and neonatal diseases

Additional interest is shown in hemophilia, transplant rejection, Usher’s syndrome, and other nutritional and metabolic diseases.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa

    Recruiting

    2 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy Spain +1
  • Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

    Recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Estonia Finland France Germany +7
  • Efficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +3
  • A Study of Teplizumab Compared to Placebo for Blood Sugar Control in Children and Young Adults Aged 1 to 25 Years with Newly Diagnosed Type 1 Diabetes

    Recruiting

    3 1
    Investigated Drugs:
    Belgium Czechia France Germany Greece Italy +4
  • Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland France +9
  • Frexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland France +6